# Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System

> **NCT04454853** · — · COMPLETED · sponsor: **Peking University Third Hospital** · enrollment: 40 (actual)

## Conditions studied

- Paraneoplastic Neurological Syndrome

## Interventions

- **OTHER:** Lung cancer
- **OTHER:** Suspected lung cancer
- **OTHER:** Positive methylated DNA

## Key facts

- **NCT ID:** NCT04454853
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454853, "Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04454853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*